Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, novembre 19
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Summit Therapeutics Inc
SMMT
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$10.50
-0.17
-1.59%
In chiusura: Nov 18, 4:00 PM EST
$10.51
0.0092
0.09%
Post-mercato: 7:58 PM EST
Get Report
Panoramica
Notizie
Grafici
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Summit Therapeutics Financials
Summit Therapeutics (SMMT) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Dow Slides 1.4% as Salesforce Leads Software Rout Before Anthropic IPO: Stock Market Today
Salesforce, ServiceNow and Intuit drag software lower ahead of Anthropic's IPO. Treasury yields slip, and Nvidia reports after the bell.
Piero Cingari
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Fall as Scott Bessent Presses Nvidia Over China Chips — BIDU, RKLB, MSTR in Focus (UPDATED)
U.S. stocks were mixed on Monday, as the Dow Jones, S&P 500, and Nasdaq 100 index futures moved in different directions.
Rishabh Mishra
Nasdaq 100 Jumps 2.8% as CoreWeave, Nvidia Climb: Stock Market Today
CoreWeave's 25.1% surge revived the AI trade, lifting chipmakers, memory and power stocks, while Nvidia shrugged off a Baird downgrade.
Piero Cingari
PRO
Summit Therapeutics Q3 Adj. EPS $(0.20) Beats $(0.28) Estimate
Summit Therapeutics (NASDAQ:SMMT) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.28) by 28.57 percent. This is a 53.85 percent decrease over losses of $(0.13) per share
Benzinga Newsdesk
Summit Therapeutics Flags Going Concern Risk Over Cash Needs
Summit Therapeutics beat second-quarter estimates but warned current cash is insufficient to fund operations for the next year.
Vandana Singh
PRO
Summit Therapeutics Q2 Adj. EPS $(0.19) Beats $(0.28) Estimate
Summit Therapeutics (NASDAQ:SMMT) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.28) by 32.14 percent. This is a 58.33 percent decrease over losses of $(0.12) per share
Benzinga Newsdesk